An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
about
Canadian Urological Association position statement on the use of transvaginal mesh.Coating with autologous plasma improves biocompatibility of mesh grafts in vitro: development stage of a surgical innovation.Treatment of anterior vaginal wall prolapse with and without polypropylene mesh: a prospective, randomized and controlled trial - Part II.Pelvic organ prolapse surgical management in Portugal and FDA safety communication have an impact on vaginal mesh.
P2860
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
@en
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
@nl
type
label
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
@en
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
@nl
prefLabel
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
@en
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
@nl
P2860
P1476
An appraisal of the Food and Drug Administration warning on urogynecologic surgical mesh.
@en
P2093
Ariana L Smith
Lindsey C Menchen
P2860
P2888
P304
P356
10.1007/S11934-012-0244-2
P50
P577
2012-06-01T00:00:00Z